Please use a PC Browser to access Register-Tadawul
Get It
Reported Earlier, Monte Rosa Therapeutics Prices $300M Underwritten Public Offering Of 11.125M Shares At $24.00 And 1.375M Pre-Funded Warrants
Monte Rosa Therapeutics, Inc. GLUE | 17.06 | -1.27% |
